Emerging Opportunities in Medical Disposables Market

A new market research report has been recently published by Transparency Market Research, titled “Medical Disposables Market - Global and U.S. Industry Analysis, Size, Share, Growth, Trends and Forecast, 2012 - 2018”. According to the research study, in 2011, the global medical disposables market was worth US$144.6 bn and is anticipated to be worth US$193.9 bn by the end of 2018, growing significantly at a 4.30% CAGR between 2012 and 2018.

Browse the full Medical Disposables Market (Drug Delivery, Wound Management Products, Non-woven Medical Disposables) - Global and U.S. Industry Analysis, Size, Share, Growth, Trends and Forecast, 2012 - 2018 report at http://www.transparencymarketresearch.com/medical-disposables-market.html

The research report has provided a detailed analysis of the global medical disposables market, emphasizing on the U.S. market. The report further talks about the market overview, product segmentation, growth drivers, restrains, and vendor analysis. The 50-page research report makes use of graphical representation such as tables and charts to showcase historical data and forecast figures.

Rising demand for healthcare due to the rising global aging population, rising prevalence of chronic conditions that need long-time therapies, and expanding volume of inpatient days and hospital admissions are some of the major factors boosting the demand for medical disposables in the coming years. On the other hand, rigid FDA and GMP approval norms and reduction in the prevalence of healthcare-associated infections are the factors that are expected to curb the growth of this market in the forecast period.

On the basis of product, the global medical disposables market has been segmented into nonwoven medical disposables, wound management disposables, drug delivery disposables, and others (such as laboratory and diagnostic disposables). Furthermore, the market has been classified on the basis of end use into home healthcare facilities, outpatient facilities, emergency care, hospitals, and physician offices. Among these, the hospitals segment is at the forefront of the U.S. medical disposables market. The demand for medical disposables is anticipated to rise in hospitals, thanks to the rising number of patient admissions, surgical procedures, and emergency visits.

Request A Sample Of This Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=388

The global medical disposables market has been further segmented on the basis of geography into North America, Asia Pacific, Europe, and Rest of the World. Among all these regions, North America exhibited strong demand for all product segments of the market in the recent years. According to the report, the U.S. medical disposables market held around 70% of the North America medical disposables market. In 2011, North America accounted for the largest share of 35% in the global medical disposables market. On the other hand, Asia Pacific is expected to witness rapid growth owing to rising awareness for healthcare. Some of the other factors that are expected to boost the demand for medical disposables in the Asia Pacific market are the huge aging population, increasing disposable income, and rising expenditure by governments on healthcare. The substantial rise of developing nations such as China and India is anticipated to propel the Asia Pacific medical disposables market.

The report also talks about the prominent companies that are operating in the global medical disposables market. The comprehensive analysis includes company overview, product portfolio, business strategies, financial overview, SWOT analysis, and recent developments. Some of the key players are Dickinson, and Company, 3M Company, Becton, Johnson & Johnson, and Covidien plc.

Key segments of the XYZ market

Product categorization of global medical disposables market:

• Drug Delivery Disposables
• Wound Management Disposables
• Nonwoven Medical Disposables
• Others

Major geographies analyzed under this research report are:

• Europe
• North America
• Asia Pacific
• Rest of the World

Contact us:

Mr. Sudip S

Transparency Market Research

90 State Street,

Suite 700,

Albany

NY - 12207

United States

Tel: +1-518-618-1030

USA - Canada Toll Free 866-552-3453

Email: sales@transparencymarketresearch.com

Website: http://www.transparencymarketresearch.com/

Auto-Injectors Market Segment Forecasts up to 2020, Research Reports- TransparencyMarketResearch

Driven by the rising incidence of conditions such as anaphylaxis in developed countries and the creation of a favorable reimbursement scenario by governments across the world, the global auto injectors market is poised to log a CAGR of 18.6% from 2014 to 2020. These findings are published in Transparency Market Research’s study, titled ‘Auto-Injectors Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2020’.

Browse the full Auto-injectors Market (Product Types: Prefilled and Fillable Auto-injectors; Therapeutic Applications: Anaphylaxis, Multiple Sclerosis, Rheumatoid Arthritis and Others; Manufacturing Design: Standardized and Customized Auto-injectors) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2020 report at http://www.transparencymarketresearch.com/global-auto-injectors-market.html

The study states that the global auto-injectors market will rise from its 2013 valuation of US$665.0 mn to rise to US$2.5 bn by 2020, with enormous opportunities existing in RoW markets and emerging economies. An alarming increase in the prevalence of rheumatoid arthritis and various food allergies will further create opportunities for the growth of the auto injectors market globally. TMR analysts identify a major roadblock standing in the way of companies trying to occupy a larger revenue share in the auto-injectors market: The high prices of auto-injectors. The price factor assumes greater importance when it comes to patients in emerging economies, where, incidentally, the most lucrative growth opportunities lie.

Even so, the demand for auto injectors will continue to rise consistently as patients opt to choose these products for their ease of use, even during self-administration. The report segments the global auto injectors market on the basis of product type, manufacturing design, therapeutic application, and geography. On the basis of product type, the market is segmented into prefilled or disposable auto injectors and fillable or reusable auto injectors. Given their unmatched ease of use, pre-filled auto injectors made up the largest segment in the auto injectors market by product type.

Brochure Download: http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=4199

Likewise, using manufacturing design as a criterion, the global auto-injectors market has been segmented into customized and standardized auto injectors. Although the standardized injectors segment was the larger one in 2013, the growth of the customized auto-injectors segment will be the fastest through the report’s forecast period.Moving further, the report segments the auto-injectors market by therapeutic application into anaphylaxis, rheumatoid arthritis, multiple sclerosis, and others. The high prevalence of anaphylaxis has created a massive demand for auto injectors for administrating drugs to people suffering from this condition. This factor has made the anaphylaxis the largest application segment in the auto injectors market.

From the geographical standpoint, the market for auto injectors is segmented into North America, Asia Pacific, Europe, and Rest of the World (RoW). Claiming a 70% stake in the global auto-injectors market, North America was seen to be the largest regional market in 2013. While the dominant position of North America will not see a drastic change, the Asia Pacific market will report the fastest rate of growth. The key recommendations of TMR’s analysts, discussed in detail in the report, include: Channeling investments into China and India, spearheading innovation in auto injectors, and improving consumer awareness through marketing campaigns.

Companies profiled in detail in the auto-injectors market report include: Pfizer, Inc., Becton, Dickinson & Co., Mylan, Inc., Antares Pharma Inc., Novartis International AG, Unilife Corp., Ypsomed Holding AG, Biogen Idec, and Scandinavian Health Ltd.